Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
CA$ 0.0050
0.00%
(0.00) 1D
10-р сарын 28, 13:31:29 (GMT-5)  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
286.61 мян
Avg. vol.
773.00
Volume
0.00
52-wk high
CA$ 0.01
52-wk low
CA$ 0.00
EPS
-CA$ 0.00
Beta
14.27
Shares outstanding
57.07 сая
Mkt. cap
286.61 мян
Avg. vol.
773.00
Volume
0.00
52-wk high
CA$ 0.01
52-wk low
CA$ 0.00
EPS
-CA$ 0.00
Beta
14.27
Shares outstanding
57.07 сая
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
HeadquartersВанкувер, Бритиш Коламбиа, Канад
SectorHealth Care
Industry-
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.77 мян
2.06 мян
2.95 мян
1.58 мян
Operating expense
34.77 мян
2.06 мян
2.95 мян
1.58 мян
Total operating expenses
34.77 мян
2.06 мян
2.95 мян
1.58 мян
Operating income
-34.77 мян
-2.06 мян
-2.95 мян
-1.58 мян
Other non operating income
-2.27 мян
-1.16 мян
-10.54 мян
-1.91 мян
EBT including unusual items
-39.64 мян
-5.83 мян
-16.55 мян
-6.82 мян
EBT excluding unusual items
-39.64 мян
-5.83 мян
-16.55 мян
-6.82 мян
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.64 мян
-5.83 мян
-16.55 мян
-6.82 мян
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.61 мян
-2.61 мян
-3.06 мян
-3.33 мян
Net interest expenses
-2.61 мян
-2.61 мян
-3.06 мян
-3.33 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.38 мян
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс